Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

3.70
Delayed Data
As of Jul 22
 +0.15 / +4.23%
Today’s Change
2.51
Today|||52-Week Range
19.23
-71.38%
Year-to-Date
No recent news for Lipocine Inc.

Today’s Trading

Previous close3.55
Today’s open3.54
Day’s range3.41 - 3.71
Volume217,293
Average volume (3 months)399,028
Market cap$67.6M
Dividend yield--
Data as of 07/22/2016

Growth & Valuation

Earnings growth (last year)+30.63%
Earnings growth (this year)-15.02%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.61

Competitors

 Today’s
change
Today’s
% change
SBPHSpring Bank Pharmace...+0.45+5.36%
CPRXCatalyst Pharmaceuti...+0.00+0.20%
DRNADicerna Pharmaceutic...-0.01-0.31%
XOMAXOMA Corp-0.01-1.21%
Data as of 07/22/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$0.00
Annual profit (last year)-$18.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts

Partner Offers

Search for Jobs